Journal articleEur J Cancer2018

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.

DOI 10.1016/j.ejca.2017.11.004 ↗ Europe PMC, retrieved 5 November 2026

Journal: Eur J Cancer
Published: 8 December 2017
Citations: 127

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 2

Builds on itOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy NCT02184195 ↗
Builds on itGemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally … NCT01585805 ↗